speb/financial-data huggingface dataset:
Financial ratios for NEPH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.71
Shares outstanding: 10856546
Market cap (USD): 18564693.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEPH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.47
Shares outstanding: 10856546
Market cap (USD): 15959122.62
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEPH — annual report dated 2024-12-31
Total revenue: 14162000
Gross profit: 8723000
Operating income: 6000
Net income: 74000
Capital expenditures: 50000
Operating cash flow: -492000
Depreciation & amortization: 137000
Net tangible assets: 7261000
Owner earnings: 161000
Return on net tangible assets (%): 2.217325437267594
Capex to operating income (%): 833.3333333333334
Buffett classification: The Gruesome
Stock price: 1.47
P/E ratio: 215.66381918918918
Shares outstanding: 10856546
Book value: 8585000
P/B ratio: 1.8589542947000581
Market cap (USD): 15959122.62
Debt to equity: 0.16435643564356436
Current ratio: 5.312419974391806
Quick ratio: 3.6382842509603073
Effective tax rate (%): 16.853932584269664
Interest coverage ratio: 6
COGS to revenue (%): 38.405592430447676
R&D to revenue (%): 6.397401496963706
SG&A to revenue (%): 54.20138398531281
Free cash flow (dilution-adjusted): -700000
Buyback yield (%): 0
Retained earnings: -144332000
Inventory turnover: 2.0799235181644358
Receivables turnover: 7.951712521055587
Capitalized R&D asset: 1905060
ROCI (R&D-adjusted, %): -0.8598010685769257
Rosenberg metric: 0.3642611683848797
FCF margin (%): -4.942804688603305
Revenue growth (%): -0.5337828346677904
Rule of 40 score: -5.476587523271095
Financial ratios for NEPH — quarterly report dated 2025-03-31
Total revenue: 4877000
Gross profit: 3154000
Operating income: 566000
Net income: 558000
Capital expenditures: 0
Operating cash flow: 322000
Depreciation & amortization: 40000
Net tangible assets: 7988000
Owner earnings: 598000
Return on net tangible assets (%): 7.4862293440160235
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.72
P/E ratio: 8.366155519713262
Shares outstanding: 10856546
Book value: 9291000
P/B ratio: 2.009822314067377
Market cap (USD): 18673259.12
Debt to equity: 0.14282639113120224
Current ratio: 5.923583662714098
Quick ratio: 4.636363636363637
COGS to revenue (%): 35.32909575558745
R&D to revenue (%): 6.048800492105802
SG&A to revenue (%): 46.2169366413779
Free cash flow (dilution-adjusted): 246000
Buyback yield (%): 0
Retained earnings: -143774000
Inventory turnover: 0.8817809621289662
Receivables turnover: 1.8218154650728426
Capitalized R&D asset: 295000
ROCI (R&D-adjusted, %): 7.22564345491868
FCF margin (%): 5.044084478162805
Rule of 40 score: 5.044084478162805
Financial ratios for NEPH — quarterly report dated 2025-06-30
Total revenue: 4419000
Gross profit: 2795000
Operating income: 248000
Net income: 237000
Capital expenditures: 0
Operating cash flow: 994000
Depreciation & amortization: 35000
Net tangible assets: 8317000
Owner earnings: 272000
Return on net tangible assets (%): 3.2704100036070702
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.09
P/E ratio: 55.85317376100629
Shares outstanding: 10856546
Book value: 9599000
P/B ratio: 4.625822808625898
Market cap (USD): 44403273.14
Debt to equity: 0.12928430044796332
Current ratio: 5.405191873589165
Quick ratio: 4.1427765237020315
Effective tax rate (%): 3.6585365853658534
Interest coverage ratio: 248
COGS to revenue (%): 36.795655125594024
R&D to revenue (%): 7.037791355510296
SG&A to revenue (%): 49.80764878931885
Free cash flow (dilution-adjusted): 923000
Buyback yield (%): 0
Retained earnings: -143537000
Inventory turnover: 0.7268663388466696
Receivables turnover: 2.166176470588235
Capitalized R&D asset: 508650
ROCI (R&D-adjusted, %): 3.2514697645189057
Rosenberg metric: -1.2169491525423728
FCF margin (%): 20.887078524553065
Revenue growth (%): -9.391019069099857
Rule of 40 score: 11.496059455453208
Financial ratios for NEPH — quarterly report dated 2025-09-30
Total revenue: 4764000
Gross profit: 2915000
Operating income: 314000
Net income: 337000
Capital expenditures: 0
Operating cash flow: 99000
Depreciation & amortization: 34000
Net tangible assets: 8746000
Owner earnings: 371000
Return on net tangible assets (%): 4.241939172193002
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.73
P/E ratio: 45.36348284452298
Shares outstanding: 10856546
Book value: 10006000
P/B ratio: 5.1320670177893275
Market cap (USD): 51351462.580000006
Debt to equity: 0.11533080151908855
Current ratio: 4.339683826509931
Quick ratio: 3.2298338062423997
Effective tax rate (%): 0.8823529411764706
COGS to revenue (%): 38.81192275398824
R&D to revenue (%): 7.094878253568431
SG&A to revenue (%): 46.788413098236774
Free cash flow (dilution-adjusted): 29000
Buyback yield (%): 0
Retained earnings: -143200000
Inventory turnover: 0.6753104455807158
Receivables turnover: 1.790304396843292
Capitalized R&D asset: 643720
ROCI (R&D-adjusted, %): 2.952920181283621
Rosenberg metric: 0.3858520900321543
FCF margin (%): 0.6087321578505458
Revenue growth (%): 7.8071961982348945
Rule of 40 score: 8.415928356085441
Financial ratios for NEPH — annual report dated 2025-12-31
Total revenue: 18789000
Gross profit: 11625000
Operating income: 1146000
Net income: 1194000
Capital expenditures: 0
Operating cash flow: 1645000
Depreciation & amortization: 140000
Net tangible assets: 8961000
Owner earnings: 1334000
Return on net tangible assets (%): 14.886731391585762
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.88
P/E ratio: 44.37181279731993
Shares outstanding: 10856546
Book value: 10202000
P/B ratio: 5.193093950205841
Market cap (USD): 52979944.48
Debt to equity: 0.10419525583218976
Current ratio: 4.056017347307553
Quick ratio: 2.8879653053848933
Effective tax rate (%): 0.9950248756218906
Interest coverage ratio: 1146
COGS to revenue (%): 38.13401458300069
R&D to revenue (%): 7.126510192133695
SG&A to revenue (%): 47.90036723614881
Free cash flow (dilution-adjusted): 1349000
Buyback yield (%): 0
Retained earnings: -143138000
Inventory turnover: 2.2168935643564356
Receivables turnover: 7.783347141673571
Capitalized R&D asset: 2234110
ROCI (R&D-adjusted, %): 11.028795659074165
Rosenberg metric: 3.2030905077262695
FCF margin (%): 7.179732822396083
Revenue growth (%): 32.671938991667844
Rule of 40 score: 39.85167181406393
Financial ratios for NEPH — quarterly report dated 2025-12-31
Total revenue: 4729000
Gross profit: 2761000
Operating income: 18000
Net income: 62000
Capital expenditures: 0
Operating cash flow: 230000
Depreciation & amortization: 32000
Net tangible assets: 8961000
Owner earnings: 94000
Return on net tangible assets (%): 1.0489900680727597
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.88
P/E ratio: 44.37181279731993
Shares outstanding: 10856546
Book value: 10202000
P/B ratio: 5.193093950205841
Market cap (USD): 52979944.48
Debt to equity: 0.10419525583218976
Current ratio: 4.056017347307553
Quick ratio: 2.8879653053848933
Effective tax rate (%): 0
COGS to revenue (%): 41.61556354408966
R&D to revenue (%): 8.352717276379785
SG&A to revenue (%): 48.974413195178684
Free cash flow (dilution-adjusted): 151000
Buyback yield (%): 0
Retained earnings: -143138000
Inventory turnover: 0.6089108910891089
Receivables turnover: 1.9589892294946147
Capitalized R&D asset: 724090
ROCI (R&D-adjusted, %): 0.5604371064545973
Rosenberg metric: -0.4556213017751479
FCF margin (%): 3.1930640727426516
Revenue growth (%): -0.7346767422334173
Rule of 40 score: 2.4583873305092343
Financial ratios for NMRA — annual report dated 2023-12-31
Total revenue: 0
Operating income: -252098000
Net income: -235925000
Capital expenditures: 117000
Operating cash flow: -163278000
Depreciation & amortization: 668000
Net tangible assets: 469076000
Owner earnings: -235374000
Return on net tangible assets (%): -50.178222718706564
Buffett classification: The Gruesome
Stock price: 17.05
Shares outstanding: 185284244
Book value: 469076000
P/B ratio: 6.7347217939097295
Market cap (USD): 3159096360.2000003
Debt to equity: 0.01115171102337361
Current ratio: 19.04659312651826
Quick ratio: 19.04659312651826
Free cash flow (dilution-adjusted): -180635000
Buyback yield (%): 0.015542419224240286
Retained earnings: -703434000
Receivables turnover: 0
Capitalized R&D asset: 276804830
ROCI (R&D-adjusted, %): -19.9582692880527
Rule of 40 score: 0
Financial ratios for NMRA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.21
Shares outstanding: 185284244
Market cap (USD): 2447604863.2400002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NMRA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -263464000
Net income: -243787000
Capital expenditures: 0
Operating cash flow: -182936000
Depreciation & amortization: 631000
Net tangible assets: 287064000
Owner earnings: -243156000
Return on net tangible assets (%): -84.70445614915141
Buffett classification: The Gruesome
Stock price: 10.6
Shares outstanding: 185284244
Book value: 287064000
P/B ratio: 6.841725142825293
Market cap (USD): 1964012986.3999999
Debt to equity: 0.00645500654906223
Current ratio: 10.508432041758683
Quick ratio: 10.508432041758683
Free cash flow (dilution-adjusted): -222926000
Buyback yield (%): 0
Retained earnings: -947221000
Capitalized R&D asset: 373931580
ROCI (R&D-adjusted, %): -35.29457315391421
Rule of 40 score: 0
Financial ratios for NMRA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.6
Shares outstanding: 185284244
Market cap (USD): 1964012986.3999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NMRA — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -70936000
Net income: -67992000
Capital expenditures: 0
Operating cash flow: -59448000
Depreciation & amortization: 157000
Net tangible assets: 228364000
Owner earnings: -67835000
Return on net tangible assets (%): -29.704769578392394
Buffett classification: The Gruesome
Stock price: 1
Shares outstanding: 185284244
Book value: 228364000
P/B ratio: 0.8113548720463821
Market cap (USD): 185284244
Debt to equity: 0.004107477535863796
Current ratio: 8.979213641488162
Quick ratio: 8.979213641488162
Free cash flow (dilution-adjusted): -68772000
Buyback yield (%): 0
Retained earnings: -1015213000
Capitalized R&D asset: 52151000
ROCI (R&D-adjusted, %): -12.893665817038901
Rule of 40 score: 0
Financial ratios for NMRA — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -54040000
Net income: -52731000
Capital expenditures: 84000
Operating cash flow: -52404000
Depreciation & amortization: 19000
Net tangible assets: 182879000
Owner earnings: -52796000
Return on net tangible assets (%): -28.86936170910821
Buffett classification: The Gruesome
Stock price: 0.73
Shares outstanding: 185284244
Book value: 182879000
P/B ratio: 0.7396010374072474
Market cap (USD): 135257498.12
Debt to equity: 0.1091486720727913
Current ratio: 10.53644356211004
Quick ratio: 10.53644356211004
Free cash flow (dilution-adjusted): -59569000
Buyback yield (%): 0
Retained earnings: -1067944000
Capitalized R&D asset: 73665170
ROCI (R&D-adjusted, %): -16.504533864439086
Rule of 40 score: 0
Financial ratios for NMRA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -57700000
Net income: -56755000
Capital expenditures: 71000
Operating cash flow: -46633000
Depreciation & amortization: 23000
Net tangible assets: 132161000
Owner earnings: -56803000
Return on net tangible assets (%): -42.98015299521039
Buffett classification: The Gruesome
Stock price: 1.82
Shares outstanding: 185284244
Book value: 132161000
P/B ratio: 2.551564562011486
Market cap (USD): 337217324.08
Debt to equity: 0.15198129554104464
Current ratio: 6.852488197507933
Quick ratio: 6.852488197507933
Interest coverage ratio: -77.24230254350736
Free cash flow (dilution-adjusted): -52629000
Buyback yield (%): 0
Retained earnings: -1124699000
Capitalized R&D asset: 88674910
ROCI (R&D-adjusted, %): -23.95229137354767
Rule of 40 score: 0
Financial ratios for NMRA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -241156000
Net income: -236928000
Capital expenditures: 218000
Operating cash flow: -206440000
Depreciation & amortization: 208000
Net tangible assets: 103871000
Owner earnings: -236938000
Return on net tangible assets (%): -228.1079415813846
Buffett classification: The Gruesome
Stock price: 1.79
Shares outstanding: 185284244
Book value: 103871000
P/B ratio: 3.1929874244014207
Market cap (USD): 331658796.76
Debt to equity: 0.5295895870839792
Current ratio: 5.871529382761702
Quick ratio: 5.871529382761702
Interest coverage ratio: -74.91643367505436
Free cash flow (dilution-adjusted): -236316000
Buyback yield (%): 0
Retained earnings: -1184149000
Capitalized R&D asset: 383871680
ROCI (R&D-adjusted, %): -47.246317052473984
Rule of 40 score: 0
Financial ratios for NMRA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -58480000
Net income: -59450000
Capital expenditures: 63000
Operating cash flow: -47955000
Depreciation & amortization: 9000
Net tangible assets: 103871000
Owner earnings: -59504000
Return on net tangible assets (%): -57.28644183650875
Buffett classification: The Gruesome
Stock price: 1.79
Shares outstanding: 185284244
Book value: 103871000
P/B ratio: 3.1929874244014207
Market cap (USD): 331658796.76
Debt to equity: 0.5295895870839792
Current ratio: 5.871529382761702
Quick ratio: 5.871529382761702
Interest coverage ratio: -28.722986247544203
Free cash flow (dilution-adjusted): -55346000
Buyback yield (%): 0
Retained earnings: -1184149000
Capitalized R&D asset: 87947320
ROCI (R&D-adjusted, %): -23.03097619247333
Rule of 40 score: 0
Financial ratios for NTBR.L — annual report dated 2022-03-31
Total revenue: 80392105.26315789
Gross profit: 16389473.684210526
Operating income: 3223684.210526316
Net income: -1747368.4210526315
Capital expenditures: 1525000
Operating cash flow: 2625000
Depreciation & amortization: 1392105.2631578948
Net tangible assets: 7310526.315789473
Owner earnings: -1880263.1578947366
Return on net tangible assets (%): -25.719942404607632
Capex to operating income (%): 47.306122448979586
Buffett classification: The Good
Stock price: 0.006973684210526316
Shares outstanding: 13760276
Book value: 27598684.210526317
P/B ratio: 0.003476970812872467
Market cap (USD): 95959.81947368421
Debt to equity: 0.15508939213349227
Current ratio: 1.1568249155929167
Quick ratio: 1.0600840625645973
Interest coverage ratio: 15.705128205128208
COGS to revenue (%): 79.61308062457036
SG&A to revenue (%): 16.37533143474418
Free cash flow (dilution-adjusted): 326315.7894736842
Buyback yield (%): 0
Retained earnings: 7772368.421052632
Inventory turnover: 34.64529914529915
Receivables turnover: 5.693597987140061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.992658455012645
FCF margin (%): 0.4059052669481817
Rule of 40 score: 0.4059052669481817
Financial ratios for NTBR.L — annual report dated 2023-03-31
Total revenue: 86079012.345679
Gross profit: 17208641.97530864
Operating income: 2606172.8395061726
Net income: 1965432.098765432
Capital expenditures: 1167901.2345679011
Operating cash flow: 3193827.160493827
Depreciation & amortization: 1502469.135802469
Net tangible assets: 8840740.74074074
Owner earnings: 2300000
Return on net tangible assets (%): 26.01591956430666
Capex to operating income (%): 44.81288488867835
Buffett classification: The Good
Stock price: 0.004074074074074074
P/E ratio: 0.028523185175879397
Shares outstanding: 13760276
Book value: 27860493.82716049
P/B ratio: 0.002012181982540878
Market cap (USD): 56060.3837037037
Debt to equity: 0.0992156688970621
Current ratio: 1.1678660299952923
Quick ratio: 1.0707512273858364
Effective tax rate (%): 17.768595041322317
Interest coverage ratio: 10.052380952380952
COGS to revenue (%): 80.00831851299411
SG&A to revenue (%): 16.964029602432447
Free cash flow (dilution-adjusted): 1383950.6172839506
Buyback yield (%): 0
Retained earnings: 9258024.691358024
Inventory turnover: 38.63227146814405
Receivables turnover: 6.476314322868289
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.36238314054825
FCF margin (%): 1.607767770064827
Revenue growth (%): 7.073962130865239
Rule of 40 score: 8.681729900930065
Financial ratios for NTBR.L — annual report dated 2024-03-31
Total revenue: 86937974.6835443
Gross profit: 20088607.594936706
Operating income: 3036708.8607594934
Net income: 2055696.2025316455
Capital expenditures: 1498734.17721519
Operating cash flow: 1103797.4683544303
Depreciation & amortization: 1797468.3544303796
Net tangible assets: 6162025.316455696
Owner earnings: 2354430.3797468357
Return on net tangible assets (%): 38.20870994248152
Capex to operating income (%): 49.353897457273874
Buffett classification: The Good
Stock price: 0.0070886075949367095
P/E ratio: 0.0474492275862069
Shares outstanding: 13760276
Book value: 25648101.265822783
P/B ratio: 0.0038030572302832893
Market cap (USD): 97541.19696202532
Debt to equity: 0.2555029118547034
Current ratio: 1.1415941721479597
Quick ratio: 1.0357875380154182
Effective tax rate (%): 24.04115996258185
Interest coverage ratio: 8.159863945578232
COGS to revenue (%): 76.89317278432173
SG&A to revenue (%): 19.61386700834292
Free cash flow (dilution-adjusted): -1427848.1012658228
Buyback yield (%): 4022.9674795144265
Retained earnings: 6574683.544303797
Inventory turnover: 35.3014705882353
Receivables turnover: 5.657413509060955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.516820057124722
FCF margin (%): -1.64237562062288
Revenue growth (%): 0.9978766187695591
Rule of 40 score: -0.6444990018533208
Financial ratios for NTBR.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 7665333.333333333
Buffett classification: The Gruesome
Stock price: 0.007066666666666666
Shares outstanding: 13760276
Book value: 28183999.999999996
P/B ratio: 0.0034501590878985716
Market cap (USD): 97239.28373333333
Debt to equity: 0.22655880404957898
Current ratio: 1.1428091849066737
Quick ratio: 1.0465288035450517
Buyback yield (%): 0
Retained earnings: 8093333.333333333
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTBR.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 8998701.2987013
Buffett classification: The Gruesome
Stock price: 0.008051948051948052
Shares outstanding: 13760276
Book value: 28977922.077922076
P/B ratio: 0.0038234980146103167
Market cap (USD): 110797.02753246753
Debt to equity: 0.14489311163895488
Current ratio: 1.0935934769947582
Quick ratio: 1.0050087361677345
Buyback yield (%): 0
Retained earnings: 9402597.402597403
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTBR.L — annual report dated 2025-03-31
Total revenue: 101441558.44155844
Gross profit: 24958441.558441557
Operating income: 4354545.454545454
Net income: 2993506.4935064935
Capital expenditures: 1894805.1948051949
Operating cash flow: 9654545.454545455
Depreciation & amortization: 2000000
Net tangible assets: 8998701.2987013
Owner earnings: 3098701.2987012984
Return on net tangible assets (%): 34.43498340308847
Capex to operating income (%): 43.51327169698778
Buffett classification: The Good
Stock price: 0.008051948051948052
P/E ratio: 0.03701245605206074
Shares outstanding: 13760276
Book value: 28977922.077922076
P/B ratio: 0.0038234980146103167
Market cap (USD): 110797.02753246753
Debt to equity: 0.14489311163895488
Current ratio: 1.0935934769947582
Quick ratio: 1.0050087361677345
Effective tax rate (%): 24.47575360419397
Interest coverage ratio: 8.686528497409325
COGS to revenue (%): 75.39623607732685
SG&A to revenue (%): 20.31109973114838
Free cash flow (dilution-adjusted): 7118181.818181818
Buyback yield (%): 0
Retained earnings: 9402597.402597403
Inventory turnover: 38.719263642340565
Receivables turnover: 6.613886536833192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.207026941862296
FCF margin (%): 7.017027269235694
Revenue growth (%): 16.682679589451485
Rule of 40 score: 23.69970685868718
Financial ratios for NVCT — annual report dated 2022-12-31
Total revenue: 0
Operating income: -19234000
Net income: -19085000
Capital expenditures: 0
Operating cash flow: -13559000
Net tangible assets: 14219000
Owner earnings: -19085000
Return on net tangible assets (%): -134.22181588016036
Buffett classification: The Gruesome
Stock price: 7.5
Shares outstanding: 31525533
Book value: 14219000
P/B ratio: 16.62856020113932
Market cap (USD): 236441497.5
Debt to equity: 0
Current ratio: 3.2985774329130293
Quick ratio: 3.2985774329130293
Free cash flow (dilution-adjusted): -15266000
Buyback yield (%): 0
Retained earnings: -31985000
Capitalized R&D asset: 13227000
ROCI (R&D-adjusted, %): -37.950885374918016
Rule of 40 score: 0
Financial ratios for NVCT — annual report dated 2023-12-31
Total revenue: 0
Operating income: -22897000
Net income: -22260000
Capital expenditures: 0
Operating cash flow: -15954000
Net tangible assets: 12201000
Owner earnings: -22260000
Return on net tangible assets (%): -182.44406196213424
Buffett classification: The Gruesome
Stock price: 8.34
Shares outstanding: 31525533
Book value: 12201000
P/B ratio: 21.549294747971476
Market cap (USD): 262922945.22
Debt to equity: 0
Current ratio: 2.7469931271477663
Quick ratio: 2.7469931271477663
Free cash flow (dilution-adjusted): -20659000
Buyback yield (%): 0
Retained earnings: -54245000
Capitalized R&D asset: 24242090
ROCI (R&D-adjusted, %): -46.79259268812459
Rule of 40 score: 0
Financial ratios for NVCT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.29
Shares outstanding: 31525533
Market cap (USD): 198295602.57
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NVCT — annual report dated 2024-12-31
Total revenue: 0
Operating income: -19847000
Net income: -19000000
Capital expenditures: 0
Operating cash flow: -12247000
Net tangible assets: 9713000
Owner earnings: -19000000
Return on net tangible assets (%): -195.61412539894988
Buffett classification: The Gruesome
Stock price: 5.41
Shares outstanding: 31525533
Book value: 9713000
P/B ratio: 17.55926423659014
Market cap (USD): 170553133.53
Debt to equity: 0
Current ratio: 2.0920845513829547
Quick ratio: 2.0920845513829547
Free cash flow (dilution-adjusted): -17105000
Buyback yield (%): 0
Retained earnings: -73245000
Capitalized R&D asset: 27587510
ROCI (R&D-adjusted, %): -55.68467205050725
Rule of 40 score: 0
Financial ratios for NVCT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.41
Shares outstanding: 31525533
Market cap (USD): 170553133.53
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NVCT — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -5568000
Net income: -5332000
Capital expenditures: 0
Operating cash flow: -4174000
Net tangible assets: 20954000
Owner earnings: -5332000
Return on net tangible assets (%): -25.446215519709842
Buffett classification: The Gruesome
Stock price: 9.77
Shares outstanding: 31525533
Book value: 20954000
P/B ratio: 14.699076902262096
Market cap (USD): 308004457.40999997
Debt to equity: 0
Current ratio: 3.2790950619969546
Quick ratio: 3.2790950619969546
Free cash flow (dilution-adjusted): -5542000
Buyback yield (%): 0
Retained earnings: -78577000
Capitalized R&D asset: 3680000
ROCI (R&D-adjusted, %): -12.643771481150715
Rule of 40 score: 0
Financial ratios for NVCT — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -6595000
Net income: -6334000
Capital expenditures: 0
Operating cash flow: -3367000
Net tangible assets: 16872000
Owner earnings: -6334000
Return on net tangible assets (%): -37.54148885727833
Buffett classification: The Gruesome
Stock price: 7.47
Shares outstanding: 31525533
Book value: 16872000
P/B ratio: 13.957783991820769
Market cap (USD): 235495731.51
Debt to equity: 0
Current ratio: 2.6647261963492848
Quick ratio: 2.6647261963492848
Free cash flow (dilution-adjusted): -5098000
Buyback yield (%): 0
Retained earnings: -84911000
Capitalized R&D asset: 6078600
ROCI (R&D-adjusted, %): -23.585440032068878
Rule of 40 score: 0
Financial ratios for NVCT — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -7794000
Net income: -7462000
Capital expenditures: 0
Operating cash flow: -4494000
Net tangible assets: 24010000
Owner earnings: -7462000
Return on net tangible assets (%): -31.078717201166178
Buffett classification: The Gruesome
Stock price: 6.02
Shares outstanding: 31525533
Book value: 24010000
P/B ratio: 7.904361043731778
Market cap (USD): 189783708.66
Debt to equity: 0
Current ratio: 3.073939708041807
Quick ratio: 3.073939708041807
Free cash flow (dilution-adjusted): -5951000
Buyback yield (%): 0
Retained earnings: -92373000
Capitalized R&D asset: 9409110
ROCI (R&D-adjusted, %): -19.077906822373986
Rule of 40 score: 0
Financial ratios for NVCT — annual report dated 2025-12-31
Total revenue: 0
Operating income: -27574000
Net income: -26442000
Capital expenditures: 0
Operating cash flow: -16009000
Net tangible assets: 18413000
Owner earnings: -26442000
Return on net tangible assets (%): -143.60506164123174
Buffett classification: The Gruesome
Stock price: 7.55
Shares outstanding: 31525533
Book value: 18413000
P/B ratio: 12.926615660131429
Market cap (USD): 238017774.15
Debt to equity: 0
Current ratio: 2.384852587244284
Quick ratio: 2.384852587244284
Free cash flow (dilution-adjusted): -22041000
Buyback yield (%): 0
Retained earnings: -99687000
Capitalized R&D asset: 31883460
ROCI (R&D-adjusted, %): -49.515744580566235
Rule of 40 score: 0
Financial ratios for NVCT — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -7617000
Net income: -7314000
Capital expenditures: 0
Operating cash flow: -3974000
Net tangible assets: 18413000
Owner earnings: -7314000
Return on net tangible assets (%): -39.72193558898604
Buffett classification: The Gruesome
Stock price: 7.55
Shares outstanding: 31525533
Book value: 18413000
P/B ratio: 12.926615660131429
Market cap (USD): 238017774.15
Debt to equity: 0
Current ratio: 2.384852587244284
Quick ratio: 2.384852587244284
Free cash flow (dilution-adjusted): -5450000
Buyback yield (%): 0
Retained earnings: -99687000
Capitalized R&D asset: 10146870
ROCI (R&D-adjusted, %): -25.754085481948387
Rule of 40 score: 0
Financial ratios for OUST — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52
Shares outstanding: 67294825
Market cap (USD): 3499330900
Buyback yield (%): 0.0012859601245483814
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OUST — annual report dated 2022-12-31
Total revenue: 41029000
Gross profit: 10930000
Operating income: -145423000
Net income: -138560000
Capital expenditures: 5147000
Operating cash flow: -110690000
Depreciation & amortization: 12186000
Net tangible assets: 102302000
Owner earnings: -131521000
Return on net tangible assets (%): -128.56151394889642
Buffett classification: The Gruesome
Stock price: 8.63
Shares outstanding: 67294825
Book value: 171619000
P/B ratio: 3.3839746167382403
Market cap (USD): 580754339.75
Debt to equity: 0.32744043491687985
Current ratio: 5.50990099009901
Quick ratio: 4.847585785975858
Interest coverage ratio: -53.98032665181886
COGS to revenue (%): 73.36030612493603
R&D to revenue (%): 156.75985278705306
SG&A to revenue (%): 224.31938385044722
Free cash flow (dilution-adjusted): -149433000
Buyback yield (%): 0.007748543044787467
Retained earnings: -441916000
Inventory turnover: 1.5409307326063584
Receivables turnover: 2.981975434261211
Capitalized R&D asset: 64317000
ROCI (R&D-adjusted, %): -35.24343385046845
FCF margin (%): -364.2131175510005
Rule of 40 score: -364.2131175510005
Financial ratios for OUST — annual report dated 2023-12-31
Total revenue: 83279000
Gross profit: 8314000
Operating income: -206517000
Net income: -374110000
Capital expenditures: 2446000
Operating cash flow: -137890000
Depreciation & amortization: 21667000
Net tangible assets: 155236000
Owner earnings: -354889000
Return on net tangible assets (%): -228.61256409595714
Buffett classification: The Gruesome
Stock price: 7.67
Shares outstanding: 67294825
Book value: 179672000
P/B ratio: 2.8727420396611603
Market cap (USD): 516151307.75
Debt to equity: 0.38903112338038204
Current ratio: 3.221331342114283
Quick ratio: 2.9369460901924302
Interest coverage ratio: -22.198968074814577
COGS to revenue (%): 90.01669088245536
R&D to revenue (%): 109.52340926283937
SG&A to revenue (%): 148.44198417368125
Free cash flow (dilution-adjusted): -198621000
Buyback yield (%): 0
Retained earnings: -816026000
Inventory turnover: 3.226799242424242
Receivables turnover: 2.083016508254127
Capitalized R&D asset: 134302390
ROCI (R&D-adjusted, %): -43.60189258619399
Rosenberg metric: -0.04067353887774616
FCF margin (%): -238.50070245800262
Revenue growth (%): 102.97594384459772
Rule of 40 score: -135.5247586134049
Financial ratios for OUST — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.3
Shares outstanding: 67294825
Market cap (USD): 423957397.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OUST — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.22
Shares outstanding: 67294825
Market cap (USD): 822342761.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OUST — annual report dated 2024-12-31
Total revenue: 111101000
Gross profit: 40460000
Operating income: -104177000
Net income: -97045000
Capital expenditures: 3088000
Operating cash flow: -33694000
Depreciation & amortization: 14740000
Net tangible assets: 163081000
Owner earnings: -85393000
Return on net tangible assets (%): -52.362323017396264
Buffett classification: The Gruesome
Stock price: 12.22
Shares outstanding: 67294825
Book value: 180911000
P/B ratio: 4.545565286245724
Market cap (USD): 822342761.5
Debt to equity: 0.11193349215912797
Current ratio: 2.803305026394308
Quick ratio: 2.5939739372146993
Interest coverage ratio: -57.14591332967636
COGS to revenue (%): 63.58268602442823
R&D to revenue (%): 52.28035751253364
SG&A to revenue (%): 77.90478933582956
Free cash flow (dilution-adjusted): -77909000
Buyback yield (%): 0
Retained earnings: -913071000
Inventory turnover: 4.302917707254675
Receivables turnover: 4.867940235727118
Capitalized R&D asset: 140419310
ROCI (R&D-adjusted, %): -34.68865329310597
Rosenberg metric: 0.35243942550158974
FCF margin (%): -70.12448132780082
Revenue growth (%): 33.408182134751854
Rule of 40 score: -36.71629919304897
Financial ratios for OUST — quarterly report dated 2025-03-31
Total revenue: 32632000
Gross profit: 13483000
Operating income: -23830000
Net income: -22017000
Capital expenditures: 552000
Operating cash flow: -4879000
Depreciation & amortization: 3040000
Net tangible assets: 151233000
Owner earnings: -19529000
Return on net tangible assets (%): -12.913186936713547
Buffett classification: The Gruesome
Stock price: 8.98
Shares outstanding: 67294825
Book value: 167943000
P/B ratio: 3.598289470236926
Market cap (USD): 604307528.5
Debt to equity: 0.11292521867538391
Current ratio: 2.572809020503284
Quick ratio: 2.395023657635178
COGS to revenue (%): 58.681662172101
R&D to revenue (%): 45.9211816621721
SG&A to revenue (%): 68.42363324344201
Free cash flow (dilution-adjusted): -13929000
Buyback yield (%): 0
Retained earnings: -935088000
Inventory turnover: 1.2677259185700098
Receivables turnover: 1.2622621073804734
Capitalized R&D asset: 14985000
ROCI (R&D-adjusted, %): -6.9684305926187005
FCF margin (%): -42.68509438587889
Rule of 40 score: -42.68509438587889
Financial ratios for OUST — quarterly report dated 2025-06-30
Total revenue: 35049000
Gross profit: 15842000
Operating income: -26822000
Net income: -20612000
Capital expenditures: 889000
Operating cash flow: -1309000
Depreciation & amortization: 3123000
Net tangible assets: 205450000
Owner earnings: -18378000
Return on net tangible assets (%): -8.94524215137503
Buffett classification: The Gruesome
Stock price: 24.25
Shares outstanding: 67294825
Book value: 221033000
P/B ratio: 7.3830582141580665
Market cap (USD): 1631899506.25
Debt to equity: 0.07987042658788507
Current ratio: 3.173516565215371
Quick ratio: 3.012011523628084
COGS to revenue (%): 54.8004222659705
R&D to revenue (%): 48.92293646038403
SG&A to revenue (%): 72.8037889811407
Free cash flow (dilution-adjusted): -15424000
Buyback yield (%): 0
Retained earnings: -955700000
Inventory turnover: 1.3815003955980723
Receivables turnover: 1.8939262941748622
Capitalized R&D asset: 27186950
ROCI (R&D-adjusted, %): -7.75288581293648
Rosenberg metric: 0.15742409075742408
FCF margin (%): -44.00696168221633
Revenue growth (%): 7.406839911743074
Rule of 40 score: -36.60012177047325
Financial ratios for OUST — quarterly report dated 2025-09-30
Total revenue: 39525000
Gross profit: 16659000
Operating income: -24251000
Net income: -21733000
Capital expenditures: 1702000
Operating cash flow: -18342000
Depreciation & amortization: 3412000
Net tangible assets: 232992000
Owner earnings: -20023000
Return on net tangible assets (%): -8.593857299821453
Buffett classification: The Gruesome
Stock price: 27.05
Shares outstanding: 67294825
Book value: 247442000
P/B ratio: 7.356572514973206
Market cap (USD): 1820325016.25
Debt to equity: 0.06425344121046549
Current ratio: 3.254624742773673
Quick ratio: 3.0785593193231615
COGS to revenue (%): 57.85199240986717
R&D to revenue (%): 44.97659709044908
SG&A to revenue (%): 58.527514231499055
Free cash flow (dilution-adjusted): -31873000
Buyback yield (%): 0
Retained earnings: -977433000
Inventory turnover: 1.384727184642403
Receivables turnover: 1.2498814154254814
Capitalized R&D asset: 34210540
ROCI (R&D-adjusted, %): -7.85548633506138
Rosenberg metric: 0.04764681868548434
FCF margin (%): -80.64010120177103
Revenue growth (%): 12.770692459128648
Rule of 40 score: -67.86940874264238
Financial ratios for OUST — quarterly report dated 2025-12-31
Total revenue: 62178000
Gross profit: 37452000
Operating income: 904000
Net income: 3985000
Capital expenditures: 21750000
Operating cash flow: -15426000
Depreciation & amortization: 3314000
Net tangible assets: 248422000
Owner earnings: -14451000
Return on net tangible assets (%): -5.817117646585245
Capex to operating income (%): 2405.9734513274334
Buffett classification: The Gruesome
Stock price: 21.64
P/E ratio: 91.3588464868256
Shares outstanding: 67294825
Book value: 261738000
P/B ratio: 5.563808132560041
Market cap (USD): 1456260013
Debt to equity: 0.06525609579044693
Current ratio: 3.926285706240937
Quick ratio: 3.5945150708845435
Effective tax rate (%): 9.411229824960218
COGS to revenue (%): 39.76647688893178
R&D to revenue (%): 24.54405095049696
SG&A to revenue (%): 34.23558171700601
Free cash flow (dilution-adjusted): -44447000
Buyback yield (%): 0
Retained earnings: -973448000
Inventory turnover: 1.0492234575235508
Receivables turnover: 1.8157871681803581
Capitalized R&D asset: 32830100
ROCI (R&D-adjusted, %): -0.18095278171002113
Rosenberg metric: 1.169657422512235
FCF margin (%): -71.483482903921
Revenue growth (%): 57.313092979127134
Rule of 40 score: -14.170389924793866
Financial ratios for OUST — annual report dated 2025-12-31
Total revenue: 169384000
Gross profit: 83436000
Operating income: -73999000
Net income: -60377000
Capital expenditures: 24893000
Operating cash flow: -39956000
Depreciation & amortization: 12889000
Net tangible assets: 248422000
Owner earnings: -72381000
Return on net tangible assets (%): -29.136308378484998
Buffett classification: The Gruesome
Stock price: 21.64
Shares outstanding: 67294825
Book value: 261738000
P/B ratio: 5.563808132560041
Market cap (USD): 1456260013
Debt to equity: 0.06525609579044693
Current ratio: 3.926285706240937
Quick ratio: 3.5945150708845435
COGS to revenue (%): 50.74151041420677
R&D to revenue (%): 38.4747083549804
SG&A to revenue (%): 54.470906342983994
Free cash flow (dilution-adjusted): -105673000
Buyback yield (%): 0
Retained earnings: -973448000
Inventory turnover: 3.647118730374268
Receivables turnover: 4.946529217650323
Capitalized R&D asset: 134185580
ROCI (R&D-adjusted, %): -19.462739505200492
Rosenberg metric: 0.7398939466978858
FCF margin (%): -62.38664808954801
Revenue growth (%): 52.45947381211691
Rule of 40 score: -9.9271742774311
Financial ratios for PFSA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -21709000
Net income: -22192000
Capital expenditures: 0
Operating cash flow: -10617386
Net tangible assets: -33960000
Owner earnings: -22192000
Buffett classification: The Gruesome
Stock price: 556.88
Shares outstanding: 530000
Book value: -33960000
Market cap (USD): 295146400
Debt to equity: -0.6204652532391048
Current ratio: 0.1782073067119796
Quick ratio: 0.1782073067119796
Interest coverage ratio: -128.45562130177515
Free cash flow (dilution-adjusted): -10617386
Buyback yield (%): 0
Retained earnings: -152214000
Capitalized R&D asset: 865220
Rule of 40 score: 0
Financial ratios for PFSA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -27706000
Net income: -35823000
Capital expenditures: 8000
Operating cash flow: -16248000
Net tangible assets: -26658000
Owner earnings: -35831000
Buffett classification: The Gruesome
Stock price: 196.88
Shares outstanding: 530000
Book value: -26658000
Market cap (USD): 104346400
Debt to equity: -0.5557431165128667
Current ratio: 0.1691077365441639
Quick ratio: 0.1691077365441639
Interest coverage ratio: -10.990083300277668
Free cash flow (dilution-adjusted): -17147000
Buyback yield (%): 0
Retained earnings: -160781000
Capitalized R&D asset: 4553240
Rule of 40 score: 0
Financial ratios for PFSA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -3570000
Net income: -8567000
Capital expenditures: 0
Operating cash flow: -5129000
Net tangible assets: -26658000
Owner earnings: -8567000
Buffett classification: The Gruesome
Stock price: 196.88
Shares outstanding: 530000
Book value: -26658000
Market cap (USD): 104346400
Debt to equity: -0.5557431165128667
Current ratio: 0.1691077365441639
Quick ratio: 0.1691077365441639
Interest coverage ratio: -142.8
Free cash flow (dilution-adjusted): -5324000
Buyback yield (%): 0
Retained earnings: -160781000
Capitalized R&D asset: 1738740
Rule of 40 score: 0
Financial ratios for PHNM.V — annual report dated 2021-11-30
Gross profit: -15455.905511811023
Capital expenditures: 4253906.299212598
Depreciation & amortization: 15455.905511811023
Buffett classification: The Gruesome
Stock price: 0.2755905511811023
Shares outstanding: 122605664
Market cap (USD): 33788962.51968504
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHNM.V — annual report dated 2022-11-30
Total revenue: 0
Gross profit: 0
Operating income: -867070.5882352941
Net income: -1490897.794117647
Capital expenditures: 3508588.970588235
Operating cash flow: -791253.6764705882
Depreciation & amortization: 0
Net tangible assets: 13385223.529411763
Owner earnings: -4999486.764705882
Return on net tangible assets (%): -37.35079024806987
Buffett classification: The Gruesome
Stock price: 0.25735294117647056
Shares outstanding: 122605664
Book value: 13385223.529411763
P/B ratio: 2.357295577915594
Market cap (USD): 31552928.235294115
Debt to equity: 0
Current ratio: 1.2642003456489181
Quick ratio: 1.2642003456489181
Free cash flow (dilution-adjusted): -791253.6764705882
Buyback yield (%): 0
Retained earnings: -13769119.852941176
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.477819263384382
Rule of 40 score: 0
Financial ratios for PHNM.V — annual report dated 2023-11-30
Total revenue: 0
Operating income: -909811.0294117646
Net income: -1372441.9117647058
Capital expenditures: 0
Operating cash flow: -672063.9705882353
Net tangible assets: 13464544.852941176
Owner earnings: -1372441.9117647058
Return on net tangible assets (%): -10.193006349300486
Buffett classification: The Gruesome
Stock price: 0.16176470588235292
Shares outstanding: 122605664
Book value: 13464544.852941176
P/B ratio: 1.472999599547417
Market cap (USD): 19833269.176470585
Debt to equity: 0
Current ratio: 0.49713420659281843
Quick ratio: 0.49713420659281843
Free cash flow (dilution-adjusted): -969425.7352941176
Buyback yield (%): 0
Retained earnings: -15141561.764705881
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.757087145155351
Rule of 40 score: 0
Financial ratios for PHNM.V — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.27142857142857146
Shares outstanding: 122605664
Market cap (USD): 33278680.228571434
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHNM.V — annual report dated 2024-11-30
Total revenue: 0
Operating income: -844154.2857142858
Net income: -850790
Capital expenditures: 0
Operating cash flow: -653897.1428571428
Net tangible assets: 14232960.714285715
Owner earnings: -850790
Return on net tangible assets (%): -5.977603796419227
Buffett classification: The Gruesome
Stock price: 0.27142857142857146
Shares outstanding: 122605664
Book value: 14232960.714285715
P/B ratio: 2.3381417890916687
Market cap (USD): 33278680.228571434
Debt to equity: 0
Current ratio: 1.5413416242698323
Quick ratio: 1.5413416242698323
Free cash flow (dilution-adjusted): -847618.5714285714
Buyback yield (%): 0
Retained earnings: -15559735.714285715
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.930981632423131
Rule of 40 score: 0
Financial ratios for PHNM.V — quarterly report dated 2025-02-28
Total revenue: 0
Operating income: -189884.02777777778
Net income: -188331.94444444444
Capital expenditures: 0
Operating cash flow: -252975
Net tangible assets: 14840288.88888889
Owner earnings: -188331.94444444444
Return on net tangible assets (%): -1.269058478945453
Buffett classification: The Gruesome
Stock price: 0.18055555555555558
Shares outstanding: 122605664
Book value: 14840288.88888889
P/B ratio: 1.4916915663516583
Market cap (USD): 22137133.77777778
Debt to equity: 0
Current ratio: 7.156849152025659
Quick ratio: 7.156849152025659
Free cash flow (dilution-adjusted): -259707.63888888888
Buyback yield (%): 0
Retained earnings: -15315852.777777778
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2795170579189084
Rule of 40 score: 0
Financial ratios for PHNM.V — quarterly report dated 2025-05-31
Total revenue: 0
Operating income: -251928.26086956525
Net income: -258492.02898550726
Capital expenditures: 0
Operating cash flow: -371558.69565217395
Net tangible assets: 15455589.855072465
Owner earnings: -258492.02898550726
Return on net tangible assets (%): -1.6724824572170642
Buffett classification: The Gruesome
Stock price: 0.23913043478260873
Shares outstanding: 122605664
Book value: 15455589.855072465
P/B ratio: 1.8969671176611964
Market cap (USD): 29318745.739130437
Debt to equity: 0
Current ratio: 4.316587387329281
Quick ratio: 4.316587387329281
Free cash flow (dilution-adjusted): -383208.69565217395
Buyback yield (%): 0
Retained earnings: -16240251.449275363
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6300138864443492
Rule of 40 score: 0
Financial ratios for PHNM.V — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: -155140.87591240875
Net income: -154189.7810218978
Capital expenditures: 0
Operating cash flow: -113758.39416058394
Net tangible assets: 15415523.357664233
Owner earnings: -154189.7810218978
Return on net tangible assets (%): -1.000224108156784
Buffett classification: The Gruesome
Stock price: 0.1532846715328467
Shares outstanding: 122605664
Book value: 15415523.357664231
P/B ratio: 1.2191327208467984
Market cap (USD): 18793568.934306566
Debt to equity: 0
Current ratio: 2.45803072586954
Quick ratio: 2.45803072586954
Free cash flow (dilution-adjusted): -115067.15328467153
Buyback yield (%): 0
Retained earnings: -16512983.21167883
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0063938298616142
Rule of 40 score: 0
Financial ratios for PHNM.V — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -132701.42857142858
Net income: -120392.85714285714
Capital expenditures: 0
Operating cash flow: -57613.571428571435
Net tangible assets: 15460564.285714287
Owner earnings: -120392.85714285714
Return on net tangible assets (%): -0.7787093337472897
Buffett classification: The Gruesome
Stock price: 0.15714285714285717
Shares outstanding: 122605664
Book value: 15460564.285714287
P/B ratio: 1.2461773054855234
Market cap (USD): 19266604.342857145
Debt to equity: 0
Current ratio: 2.063814708323523
Quick ratio: 2.063814708323523
Free cash flow (dilution-adjusted): -57613.571428571435
Buyback yield (%): 0
Retained earnings: -16279526.42857143
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8583220257623196
Rule of 40 score: 0
Financial ratios for PHNM.V — annual report dated 2025-11-30
Total revenue: 0
Operating income: -728156.4285714286
Net income: -719790.7142857143
Capital expenditures: 0
Operating cash flow: -795387.8571428572
Net tangible assets: 15460564.285714287
Owner earnings: -719790.7142857143
Return on net tangible assets (%): -4.655656164832276
Buffett classification: The Gruesome
Stock price: 0.15714285714285717
Shares outstanding: 122605664
Book value: 15460564.285714287
P/B ratio: 1.2461773054855234
Market cap (USD): 19266604.342857145
Debt to equity: 0
Current ratio: 2.063814708323523
Quick ratio: 2.063814708323523
Free cash flow (dilution-adjusted): -815077.1428571428
Buyback yield (%): 0
Retained earnings: -16279526.42857143
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.709766183917701
Rule of 40 score: 0
Financial ratios for PNTR.V — annual report dated 2022-05-31
Total revenue: 0
Operating income: -550197.6377952755
Net income: -551540.157480315
Capital expenditures: 334781.88976377953
Operating cash flow: -209099.2125984252
Net tangible assets: 720109.4488188976
Owner earnings: -886322.0472440945
Return on net tangible assets (%): -123.08157443258298
Buffett classification: The Gruesome
Stock price: 0.12598425196850394
Shares outstanding: 72113222
Book value: 720109.4488188976
P/B ratio: 12.616318735450319
Market cap (USD): 9085130.330708662
Debt to equity: 0
Current ratio: 1.7427862316392162
Quick ratio: 1.7427862316392162
Free cash flow (dilution-adjusted): -895911.811023622
Buyback yield (%): 0
Retained earnings: -28046677.16535433
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -76.40472412876869
Rule of 40 score: 0
Financial ratios for PNTR.V — annual report dated 2023-05-31
Total revenue: 0
Operating income: -138972.0588235294
Net income: -736230.1470588235
Capital expenditures: 13045.588235294117
Operating cash flow: -115131.61764705881
Net tangible assets: -63774.99999999999
Owner earnings: -749275.7352941176
Buffett classification: The Gruesome
Stock price: 0.07352941176470588
Shares outstanding: 72113222
Book value: -63775
Market cap (USD): 5302442.794117647
Debt to equity: 0
Current ratio: 0.4939957166896129
Quick ratio: 0.4939957166896129
Free cash flow (dilution-adjusted): -128177.20588235294
Buyback yield (%): 0
Retained earnings: -26926877.20588235
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PNTR.V — annual report dated 2024-05-31
Total revenue: 0
Operating income: -313759.1240875912
Net income: -291704.37956204376
Capital expenditures: 0
Operating cash flow: -63016.78832116788
Net tangible assets: -179831.38686131386
Owner earnings: -291704.37956204376
Buffett classification: The Gruesome
Stock price: 0.12408759124087591
Shares outstanding: 72113222
Book value: -179831.38686131386
Market cap (USD): 8948356.014598541
Debt to equity: 0
Current ratio: 0.05128323798199301
Quick ratio: 0.05128323798199301
Free cash flow (dilution-adjusted): -63016.78832116788
Buyback yield (%): 0
Retained earnings: -27022035.03649635
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0